ESR1 and metastatic neoplasm: In 2025, an estimated 170,000 women in the United States are living with mBC (7), and approximately 60% of metastatic breast tumors are ER-positive (8).Therefore, a biopsy to determine ER status is recommended at diagnosis, first recurrence, or instances of metastatic disease (9).